Izabella Tyszler

Izabella (Izzy) Tyszler is an experienced professional with a diverse background in the biopharmaceutical industry. Izabella (Izzy) currently serves as the VP, Commercial at Zevra Therapeutics, a rare disease therapeutics company focused on providing life-changing treatments to patients with unmet needs. Prior to this, Izzy was a Board Member at the Neuromuscular Disease Foundation, where they worked to enhance the quality of life for individuals with GNE Myopathy through advocacy, education, outreach, and funding critical research.

Previously, Izzy held positions at IMT BioPharma Consulting, Orphazyme A/S, AveXis, Inc., Kastle Therapeutics, Marathon Pharmaceuticals, Lundbeck, Johnson & Quin, Inc., and Schering Pharmaceuticals. In these roles, they gained expertise in areas such as biopharmaceutical commercial executive, marketing and field execution, gene therapy brand lead, marketing director, and associate director of specialty pharmacy and managed care.

Throughout their career, Izzy has demonstrated a talent for strategic planning, alliance management, marketing and sales, and team leadership. Izabella (Izzy) has successfully launched and promoted various therapeutic products and has contributed to important milestones in product development and commercialization.

Izabella (Izzy) Tyszler pursued a Bachelor of Science degree in Marketing with a minor in Sociology at DePaul University. No further information regarding specific years or additional educational background is provided.